Pharmaceutical Executive-05-01-2021

A panel of pharma digital leaders discusses pathways for technology and data scale-up—and the skills, mindset, and C-suite influence needed to drive true digital transformation.

Early career ‘assist’ ignites calling in data and healthcare disruption.

Learning from others and leading by example provides full-circle success.

Going all-in on accelerating the promise of cell therapy at larger scale.

Script change from destined life in research to wild pace of biotech pays off.

From big pharma to underdog biotech, a mission to empower.

Applying a love for numbers in tackling drug-access delays around the world.

Bridging science and business with the end user in mind.

Excelling in specialty launch while paying it forward.

A passion for building the business engine behind treatments for rare disease.

Throwback scientist and entrepreneur leads quest to maximize gains in population health.

Startup CEO touts immunology technology to cure cancer and more.

Launching a big pharma biotech incubator during the pandemic.

Academic-focused leader advocates questioning and communicating to advance science.

Pharm Exec profiles 13 diverse leaders vital to the future of the biopharma industry.

Adding context to Pfizer’s orbit-busting, first-quarter earnings.

Amgen is collaborating on two digital health initiatives aimed at improving heart failure care and rehabilitation.

A deeper understanding of the differing age-group dynamics is key.

The progress and stumbling blocks in building a formal EU system.

Looking Back at 1994–1996.

Pharm Exec's 2021 class of EPL winners showcase the many career trajectories through biopharma.

Click the title above for a link to open the Pharmaceutical Executive May 2021 issue in an interactive PDF format.

Pressure on to advance the three separate fee plans.

The shift to clinical-grade support offers great opportunity.